{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T22:26:00Z","timestamp":1772058360817,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T00:00:00Z","timestamp":1515369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1208\/s12249-017-0946-3","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T22:25:17Z","timestamp":1515450317000},"page":"1274-1286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Structural Elucidation of Poloxamer 237 and Poloxamer 237\/Praziquantel Solid Dispersions: Impact of Poly(Vinylpyrrolidone) over Drug Recrystallization and Dissolution"],"prefix":"10.1208","volume":"19","author":[{"given":"Silvina","family":"Orlandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josefina","family":"Priotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herm\u00ednio P.","family":"Diogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio J.","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa G.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,8]]},"reference":[{"key":"946_CR1","unstructured":"WHO, 2017a. World Health Organization. Media Center. Schistosomiasis. \n                    http:\/\/www.who.int\/mediacentre\/factsheets\/fs115\/en\/\n                    \n                  . Accessed 10 Aug 2017."},{"key":"946_CR2","unstructured":"WHO, 2017b. World Health Organization. Schistosomiasis. Strategy. \n                    http:\/\/www.who.int\/schistosomiasis\/strategy\/en\/\n                    \n                  . Accessed 10 Aug 2017."},{"issue":"2","key":"946_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ejpb.2004.03.001","volume":"58","author":"M Lindenberg","year":"2004","unstructured":"Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm. 2004;58(2):265\u201378. \n                    https:\/\/doi.org\/10.1016\/j.ejpb.2004.03.001\n                    \n                  .","journal-title":"Eur J Pharm Biopharm"},{"issue":"11","key":"946_CR4","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1248\/cpb.47.1629","volume":"47","author":"P Torre De La","year":"1999","unstructured":"De La Torre P, Torrado S, Torrado S. Preparation, dissolution and characterization of praziquantel solid dispersions. Chem Pharm Bull. 1999;47(11):1629\u201333. \n                    https:\/\/doi.org\/10.1248\/cpb.47.1629\n                    \n                  .","journal-title":"Chem Pharm Bull"},{"issue":"1","key":"946_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.actatropica.2013.06.011","volume":"128","author":"TF Frezza","year":"2013","unstructured":"Frezza TF, Gremi\u00e3o MP, Zanotti-Magalh\u00e3es EA, Magalh\u00e3es LA, Ribeiro de Souza AL, Allegretti SM. Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay. Acta Trop. 2013;128(1):70\u20135. \n                    https:\/\/doi.org\/10.1016\/j.actatropica.2013.06.011\n                    \n                  .","journal-title":"Acta Trop"},{"issue":"1","key":"946_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000357","volume":"3","author":"T Meyer","year":"2009","unstructured":"Meyer T, Sekljic H, Fuchs S, Bothe H, Schollmeyer D, Miculka C. Taste, a new incentive to switch to (R)-praziquantel in schistosomiasis treatment. PLoS Negl Trop Dis. 2009;3(1):e357. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0000357\n                    \n                  .","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"946_CR7","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ijpharm.2017.05.053","volume":"533","author":"B Perissutti","year":"2017","unstructured":"Perissutti B, Passerini N, Trastullo R, Keiser J, Zanolla D, Zingone G, et al. An explorative analysis of process and formulation variables affecting comilling in a vibrational mill: the case of praziquantel. Int J Pharm. 2017;533(2):402\u201312. \n                    https:\/\/doi.org\/10.1016\/j.ijpharm.2017.05.053\n                    \n                  .","journal-title":"Int J Pharm"},{"issue":"2","key":"946_CR8","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.ijpharm.2015.11.026","volume":"496","author":"EC Arr\u00faa","year":"2015","unstructured":"Arr\u00faa EC, Ferreira MJG, Salomon CJ, Nunes TG. Elucidating the guest-host interactions and complex formation of praziquantel and cyclodextrin derivatives by 13C and 15N solid-state NMR spectroscopy. Int J Pharm. 2015;496(2):812\u201321. \n                    https:\/\/doi.org\/10.1016\/j.ijpharm.2015.11.026\n                    \n                  .","journal-title":"Int J Pharm"},{"issue":"3","key":"946_CR9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1590\/S1984-82502010000300010","volume":"46","author":"MV Chaud","year":"2010","unstructured":"Chaud MV, Tamascia P, de Lima AC, Paganelli MO, Gremi\u00e3o MPD, de Freitas O. Solid dispersions with hydrogenated castor oil increase solubility, dissolution rate and intestinal absorption of praziquantel. Braz J Pharm Sci. 2010;46(3):473\u201381. \n                    https:\/\/doi.org\/10.1590\/S1984-82502010000300010\n                    \n                  .","journal-title":"Braz J Pharm Sci"},{"issue":"2","key":"946_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4103\/0973-8398.154689","volume":"9","author":"O Bagade","year":"2015","unstructured":"Bagade O, Shete A, Dhole S, Pujari R, Raskar V, Kharat P. Design and statistical optimisation of praziquantel tablets by using solid dispersion approach. Asian J Pharm. 2015;9(2):83\u201392. \n                    https:\/\/doi.org\/10.4103\/0973-8398.154689\n                    \n                  .","journal-title":"Asian J Pharm"},{"issue":"2","key":"946_CR11","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s10973-016-5759-1","volume":"127","author":"PR Dametto","year":"2017","unstructured":"Dametto PR, Dametto AC, Polese L, Ribeiro CA, Chorilli M, de Freitas O. Development and physicochemical characterization of solid dispersions containing praziquantel for the treatment of schistosomiasis. J Therm Anal Calorim. 2017;127(2):1693\u2013706. \n                    https:\/\/doi.org\/10.1007\/s10973-016-5759-1\n                    \n                  .","journal-title":"J Therm Anal Calorim"},{"issue":"9","key":"946_CR12","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1016\/j.xphs.2015.10.008","volume":"105","author":"S Baghel","year":"2016","unstructured":"Baghel S, Cathcart H, O'Reilly NJ. Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs. J Pharm Sci. 2016;105(9):2527\u201344. \n                    https:\/\/doi.org\/10.1016\/j.xphs.2015.10.008\n                    \n                  .","journal-title":"J Pharm Sci"},{"issue":"4","key":"946_CR13","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1021\/mp500702s","volume":"12","author":"Y Tian","year":"2015","unstructured":"Tian Y, Jones DS, Andrews GP. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems. Mol Pharm. 2015;12(4):1180\u201392. \n                    https:\/\/doi.org\/10.1021\/mp500702s\n                    \n                  .","journal-title":"Mol Pharm"},{"issue":"10","key":"946_CR14","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1023\/B:PHAM.0000045226.42859.b8","volume":"21","author":"P Gupta","year":"2004","unstructured":"Gupta P, Kakumanu VK, Bansal AK. Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective. Pharm Res. 2004;21(10):1762\u20139. \n                    https:\/\/doi.org\/10.1023\/B:PHAM.0000045226.42859.b8\n                    \n                  .","journal-title":"Pharm Res"},{"issue":"1-2","key":"946_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10847-008-9490-9","volume":"63","author":"J Shah","year":"2009","unstructured":"Shah J, Vasanti S, Anroop B, Vyas H. Enhancement of dissolution rate of valdecoxib by solid dispersions technique with PVP K 30 & PEG 4000: preparation and in vitro evaluation. J Incl Phenom Macrocycl Chem. 2009;63(1-2):69\u201375. \n                    https:\/\/doi.org\/10.1007\/s10847-008-9490-9\n                    \n                  .","journal-title":"J Incl Phenom Macrocycl Chem"},{"issue":"1-2","key":"946_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ijpharm.2010.05.023","volume":"395","author":"JH Joe","year":"2010","unstructured":"Joe JH, Lee WM, Park YJ, Joe KH, DH O, Seo YG, et al. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus. Int J Pharm. 2010;395(1-2):161\u20136. \n                    https:\/\/doi.org\/10.1016\/j.ijpharm.2010.05.023\n                    \n                  .","journal-title":"Int J Pharm"},{"issue":"2","key":"946_CR17","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.ijpharm.2016.08.009","volume":"511","author":"ED Costa","year":"2016","unstructured":"Costa ED, Priotti J, Orlandi S, Leonardi D, Lamas MC, Nunes TG, et al. Unexpected solvent impact in the crystallinity of praziquantel\/poly(vinylpyrrolidone) formulations. A solubility, DSC and solid-state NMR study. Int J Pharm. 2016;511(2):983\u201393. \n                    https:\/\/doi.org\/10.1016\/j.ijpharm.2016.08.009\n                    \n                  .","journal-title":"Int J Pharm"},{"key":"946_CR18","first-page":"159","volume":"5","author":"DR Devi","year":"2013","unstructured":"Devi DR, Sandhya P, Hari BV. Poloxamer: a novel functional molecule for drug delivery and gene therapy. J Pharm Sci Res. 2013;5:159\u201365.","journal-title":"J Pharm Sci Res"},{"issue":"10","key":"946_CR19","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1039\/C4PY00039K","volume":"5","author":"A Pitto-Barry","year":"2014","unstructured":"Pitto-Barry A, Barry NPE. Pluronic\u00ae block-copolymers in medicine: from chemical and biological versatility to rationalisation and clinical advances. Polym Chem. 2014;5(10):3291\u20137. \n                    https:\/\/doi.org\/10.1039\/C4PY00039K\n                    \n                  .","journal-title":"Polym Chem"},{"issue":"10","key":"946_CR20","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1021\/acs.molpharmaceut.7b00477","volume":"14","author":"M Beck-Broichsitter","year":"2017","unstructured":"Beck-Broichsitter M, Bohr A, Ruge CA. Poloxamer-decorated polymer nanoparticles for lung surfactant compatibility. Mol Pharm. 2017;14(10):3464\u201372. \n                    https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00477\n                    \n                  .","journal-title":"Mol Pharm"},{"issue":"4","key":"946_CR21","first-page":"783","volume":"25","author":"EA Essa","year":"2012","unstructured":"Essa EA, Balata GF. Preparation and characterization of domperidone solid dispersions. Pak J Pharm Sci. 2012;25(4):783\u201391.","journal-title":"Pak J Pharm Sci"},{"key":"946_CR22","first-page":"145","volume":"45","author":"M,M,Y Rao","year":"2011","unstructured":"Rao M,M,Y, Khole I, Munjapara G. Characterization of solid dispersions of simvastatin with PVP K30 and Poloxamer 188. Ind J Pharm Edu Res. 2011;45:145\u201352.","journal-title":"Ind J Pharm Edu Res"},{"issue":"3","key":"946_CR23","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s10973-012-2885-2","volume":"113","author":"E Fousteris","year":"2013","unstructured":"Fousteris E, Tarantili PA, Karavas E, Bikiaris D. Poly(vinyl pyrrolidone)\u2013poloxamer-188 solid dispersions prepared by hot melt extrusion. J Therm Anal Calorim. 2013;113(3):1037\u201347. \n                    https:\/\/doi.org\/10.1007\/s10973-012-2885-2\n                    \n                  .","journal-title":"J Therm Anal Calorim"},{"issue":"2","key":"946_CR24","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1021\/mp500661v","volume":"12","author":"Z Chen","year":"2015","unstructured":"Chen Z, Liu Z, Qian F. Crystallization of bifonazole and acetaminophen within the matrix of semicrystalline, PEO-PPO-PEO triblock copolymers. Mol Pharm. 2015;12(2):590\u20139. \n                    https:\/\/doi.org\/10.1021\/mp500661v\n                    \n                  .","journal-title":"Mol Pharm"},{"key":"946_CR25","unstructured":"United States Pharmacopeia and National Formulary (USP 30 NF 25). Rockville, MD: United States Pharmacopeial Convention; 2007."},{"issue":"6","key":"946_CR26","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1002\/jps.20061","volume":"93","author":"JJ Moura Ramos","year":"2004","unstructured":"Moura Ramos JJ, Taveira-Marques R, Diogo HP. Estimation of the fragility index of indomethacin by DSC using the heating and cooling rate dependency of the glass transition. J Pharm Sci. 2004;93(6):1503\u20137. \n                    https:\/\/doi.org\/10.1002\/jps.20061\n                    \n                  .","journal-title":"J Pharm Sci"},{"issue":"2","key":"946_CR27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0022-2364(82)90199-8","volume":"49","author":"WT Dixon","year":"1982","unstructured":"Dixon WT, Schaefer J, Sefcik MD, Stejskal EO, McKay RA. Total suppression of sidebands in CPMAS C-13 NMR. J Magn Reson. 1982;49(2):341\u20135. \n                    https:\/\/doi.org\/10.1016\/0022-2364(82)90199-8\n                    \n                  .","journal-title":"J Magn Reson"},{"issue":"3","key":"946_CR28","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1021\/cr000060n","volume":"102","author":"W Kolodziejski","year":"2002","unstructured":"Kolodziejski W, Klinowski J. Kinetics of cross-polarization in solid-state NMR: a guide for chemists. Chem Rev. 2002;102(3):613\u201328. \n                    https:\/\/doi.org\/10.1021\/cr000060n\n                    \n                  .","journal-title":"Chem Rev"},{"issue":"1","key":"946_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3109\/10837450.2015.1116568","volume":"22","author":"MK Oo","year":"2015","unstructured":"Oo MK, Mandal UK, Chatterjee B. Polymeric behavior evaluation of PVP K30-poloxamer binary carrier for solid dispersed nisoldipine by experimental design. Pharm Dev Technol. 2015;22(1):2\u201312. \n                    https:\/\/doi.org\/10.3109\/10837450.2015.1116568\n                    \n                  .","journal-title":"Pharm Dev Technol"},{"issue":"1-2","key":"946_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ijpharm.2012.06.060","volume":"436","author":"N Kola\u0161inac","year":"2012","unstructured":"Kola\u0161inac N, Kachrimanis K, Hom\u0161ek I, Gruji\u0107 B, \u00d0uri\u0107 Z, Ibri\u0107 S. Solubility enhancement of desloratadine by solid dispersion in poloxamers. Int J Pharm. 2012;436(1-2):161\u201370. \n                    https:\/\/doi.org\/10.1016\/j.ijpharm.2012.06.060\n                    \n                  .","journal-title":"Int J Pharm"},{"issue":"5","key":"946_CR31","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ajps.2015.04.003","volume":"10","author":"S-Y Chan","year":"2015","unstructured":"Chan S-Y, Chung Y-Y, Cheah X-Z, Tan EY-L, Quah J. The characterization and dissolution performances of spray dried solid dispersion of ketoprofen in hydrophilic carriers. Asian J Pharm Sci. 2015;10(5):372\u201385. \n                    https:\/\/doi.org\/10.1016\/j.ajps.2015.04.003\n                    \n                  .","journal-title":"Asian J Pharm Sci"},{"issue":"5","key":"946_CR32","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1021\/mp500872g","volume":"12","author":"Y Hasegawa","year":"2015","unstructured":"Hasegawa Y, Higashi K, Yamamoto K, Moribe K. Direct evaluation of molecular states of piroxicam\/poloxamer nanosuspension by suspended-state NMR and Raman spectroscopies. Mol Pharm. 2015;12(5):1564\u201372. \n                    https:\/\/doi.org\/10.1021\/mp500872g\n                    \n                  .","journal-title":"Mol Pharm"},{"issue":"1-2","key":"946_CR33","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0008-6215(99)00195-0","volume":"322","author":"S Hediger","year":"1999","unstructured":"Hediger S, Emsley L, Fischer M. Solid-state NMR characterization of hydration effects on polymer mobility in onion cell-wall material. Carbohydr Res. 1999;322(1-2):102\u201312. \n                    https:\/\/doi.org\/10.1016\/S0008-6215(99)00195-0\n                    \n                  .","journal-title":"Carbohydr Res"},{"issue":"10","key":"946_CR34","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1016\/S0032-3861(99)00518-2","volume":"41","author":"SA Reinsberg","year":"2000","unstructured":"Reinsberg SA, Ando S, Harris RK. Fluorine-19 NMR investigation of poly(trifluoroethylene). Polymer. 2000;41(10):3729\u201336. \n                    https:\/\/doi.org\/10.1016\/S0032-3861(99)00518-2\n                    \n                  .","journal-title":"Polymer"},{"key":"946_CR35","volume-title":"Spectroscopy of polymers","author":"JL Koenig","year":"1999","unstructured":"Koenig JL. Spectroscopy of polymers. 2nd ed. New York: Elsevier Science Inc; 1999.","edition":"2"},{"issue":"1","key":"946_CR36","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ijpharm.2015.09.019","volume":"495","author":"R Trastullo","year":"2015","unstructured":"Trastullo R, Dolci LS, Passerini N, Albertini B. Development of flexible and dispersible oral formulations containing praziquantel for potential schistosomiasis treatment of pre-school age children. Int J Pharm. 2015;495(1):536\u201350. \n                    https:\/\/doi.org\/10.1016\/j.ijpharm.2015.09.019\n                    \n                  .","journal-title":"Int J Pharm"},{"issue":"13","key":"946_CR37","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1016\/0032-3861(87)90382-X","volume":"28","author":"DJ Blundell","year":"1987","unstructured":"Blundell DJ. On the interpretation of multiple melting peaks in poly(ether ether ketone). Polymer. 1987;28(13):2248\u201351. \n                    https:\/\/doi.org\/10.1016\/0032-3861(87)90382-X\n                    \n                  .","journal-title":"Polymer"},{"issue":"19","key":"946_CR38","doi-asserted-by":"publisher","first-page":"6221","DOI":"10.1021\/ma990669u","volume":"32","author":"A Alizadeh","year":"1999","unstructured":"Alizadeh A, Richardson L, Xu J, McCartney S, Marand H, Cheung Y, et al. Influence of structural and topological constraints on the crystallization and melting behavior of polymers. 1. Ethylene\/1-octene copolymers. Macromolecules. 1999;32(19):6221\u201335. \n                    https:\/\/doi.org\/10.1021\/ma990669u\n                    \n                  .","journal-title":"Macromolecules"},{"issue":"1","key":"946_CR39","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/jps.23345","volume":"102","author":"M Nasu","year":"2013","unstructured":"Nasu M, Nemoto T, Mimura H, Sako K. Development of qualitative and quantitative analysis methods in pharmaceutical application with new selective signal excitation methods for 13C solid-state nuclear magnetic resonance using 1H T1rho relaxation time. J Pharm Sci. 2013;102(1):154\u201361. \n                    https:\/\/doi.org\/10.1002\/jps.23345\n                    \n                  .","journal-title":"J Pharm Sci"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-017-0946-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-017-0946-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-017-0946-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T20:06:45Z","timestamp":1543435605000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-017-0946-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,8]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["946"],"URL":"https:\/\/doi.org\/10.1208\/s12249-017-0946-3","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,8]]}}}